SR
Insider
Samraat S. Raha
President and CEOSamraat S. Raha (President and CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in MYGN. Across 1 priced purchase filing, the average 21-session return was -5.2% from execution and -5.2% from disclosure (delay-adjusted; derived). The largest single filing was $200K of MYGN (40,000 sh × $5.00, as filed), executed Mar 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-5.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-5.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$200K
shares × price, as filed
Last traded
Mar 9
Filed Mar 9
Volume by month
Buys $200K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MYGN
MYGN
MYGN · 1 buy · 0 sells
1 filing
Recent filings
MYGNPURCHASE
MYRIAD GENETICS INC
View filing →
$200K40,000 sh × $5.00
Exec Mar 9
Filed Mar 9 · 7:03 PM ET